QH106
/ Anhui Provincial Hospital
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 18, 2025
Allogeneic CD7 CAR γδ T Cells Therapy Recurrent/Refractory Leukemia
(clinicaltrials.gov)
- P1 | N=9 | Not yet recruiting | Sponsor: Anhui Provincial Hospital
New P1 trial • Hematological Malignancies • Leukemia • Lymphoma • Oncology
1 to 1
Of
1
Go to page
1